2 Years • 15 Seats • PCI Approved • NAAC A Grade • Komarapalayam, Namakkal
2 Years
4 semesters, full time
15 Seats
of 90 across 6 M.Pharm specialisations
₹75,000/year
management quota tuition
B.Pharm, 50%
45% for SC/ST, GPAT preferred
A medicine cannot be sold because it works. It can be sold because a regulator has been shown, in a prescribed format, that it works, that it is safe, and that it is made under controlled conditions. Assembling that proof and defending it is the work of regulatory affairs.
M.Pharm Pharmaceutical Regulatory Affairs is a two-year postgraduate specialisation that teaches the law, the formats and the submission routes that govern a pharmaceutical product from development through approval and across its whole marketed life. Learners study the Drugs and Cosmetics Act 1940 and its Rules, Schedule M and good manufacturing practice, the Common Technical Document and eCTD structure, CDSCO and DCGI procedures, clinical trial regulation under the New Drugs and Clinical Trials Rules 2019, pharmacovigilance and periodic safety reporting, labelling and packaging compliance, and the pathways of the international agencies Indian exporters file with.
Who this suits. Regulatory affairs is a writing, reading and compliance discipline more than a laboratory one. It rewards precision, patience with documentation, and the ability to read a guideline and work out exactly what it demands. If you would rather be at a bench than at a desk, consider Pharmaceutics, Pharmacology or Pharmaceutical Chemistry instead.
Semester content follows the Pharmacy Council of India regulations for M.Pharm and the affiliating university syllabus. Confirm the current syllabus with the department before admission.
India — new drug approval, import licences, clinical trial permission
India — manufacturing and sale licences, Schedule M inspections
United States — ANDA, NDA, DMF submissions for exporters
European Union — centralised and decentralised procedures
United Kingdom — post-Brexit national submissions
Global tenders and public health procurement
ICH guidelines and the Common Technical Document format are taught as the common framework that links these agencies, because a single dossier structure serves most of them with regional adaptation.
Pharmaceutical manufacturers, CROs, regulatory consultancies
Formulation and API companies preparing CTD submissions
Export-focused manufacturers filing with US FDA, EMA, WHO
Packaging development and quality assurance teams
Safety departments, CROs, marketing authorisation holders
GMP-regulated manufacturing sites
Clinical research organisations and hospital trial sites
Consultancies tracking guideline and law changes
The median salary of placed M.Pharm graduates from JKKN College of Pharmacy was ₹6,23,000 for the 2023-24 graduating batch, with 37 of 49 graduates placed and 6 continuing to higher studies.
Source: JKKN College of Pharmacy NIRF 2025 submission to the Ministry of Education, published at /pdf/NIRF-2025-Pharmacy.pdf. This is the college-wide M.Pharm figure; Regulatory Affairs is a new specialisation and does not yet have its own placement history.
| Seats, this specialisation | 15 |
| Total M.Pharm intake | 90 across 6 specialisations |
| Tuition, management quota | ₹75,000 / year |
| Tuition, government quota | Tamil Nadu fee committee norms |
| Duration | 2 years, 4 semesters |
Hostel, transport and examination fees are additional. Confirm the current year fee on the fee structure page or on +91 93458 55001.
Drug approval, dossiers and compliance
15 seats
Six specialisations, 15 seats each, 90 seats in total. See the M.Pharm programme page for a full comparison, or the M.Pharm admission page for the 2026-27 application process.
15 seats • PCI approved • NAAC A Grade • Komarapalayam, Namakkal district
